drugset / Trial / NCT00407654

VEGF Trap in Treating Patients With Previously Treated Metastatic Colorectal Cancer

NCT00407654

Phase 2 Completed 75 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

This phase II trial is studying how well VEGF Trap works in treating patients with previously treated metastatic colorectal cancer. VEGF Trap may stop the growth of colorectal cancer by blocking blood flow to the tumor.

Timeline

Start
2006-10
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Aflibercept Protein / enzyme biologic Intravenous

Indications